Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds
Primary Purpose
Wound Infection
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Debridement
Sponsored by
About this trial
This is an interventional treatment trial for Wound Infection
Eligibility Criteria
Inclusion Criteria:
- Infected wound requiring hospital admission
- Infected wound requiring an operative intervention
- Wound can be located anywhere on the body
- Patient able and willing to comply with all study requirements
Exclusion Criteria:
- Planned free tissue flap for soft tissue reconstruction
- Wound located over exposed joint implant
- Wound located over exposed hardware
- Disease or treatment causing substantial immunosuppression
- History of collagen vascular disease
- Transplant recipient
- Venous stasis ulcer
- Radiation-induced ulcer
- Contraindication for use of negative pressure wound therapy with instillation of normal saline
- Unable or unwilling to comply with study requirements
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
2 operations
3 or more operations
Arm Description
Subjects in this arm will receive a maximum of two surgical debridements of their wound.
Subjects in this arm will receive three or more surgical debridements of their wound.
Outcomes
Primary Outcome Measures
Number of post-hospital discharge complications between subjects who received 2 versus 3 or more debridement operations prior to closure.
Secondary Outcome Measures
Full Information
NCT ID
NCT02559453
First Posted
September 23, 2015
Last Updated
September 10, 2019
Sponsor
Georgetown University
1. Study Identification
Unique Protocol Identification Number
NCT02559453
Brief Title
Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds
Official Title
A Randomized Trial Comparing the Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds Requiring Hospitalization
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Unknown status
Study Start Date
September 2015 (undefined)
Primary Completion Date
March 2020 (Anticipated)
Study Completion Date
June 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Georgetown University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
We have designed this study to determine whether performing two, compared with ≥3 operations has an effect on key clinical outcomes after discharge from the hospital of an infected wound that requires admission. Each arm of this study represents the two commonly practiced standard of care treatment plans for patients presenting with infected wounds. It is currently unknown which SoC option provides the best patient outcome.
Detailed Description
There is a lack of consensus about whether or not a patient with an infected wound requires more than 2 surgical procedures. For patients admitted for an infected wound this study will investigate whether 2, compared with ≥3, operative interventions results in better outcomes. All patients admitted for an infected wound will be assessed for eligibility in the study. If eligible, subjects will be randomized into Cohort A (2 operative visits) or Cohort B (≥3 operative visits). Subjects will then be followed during the hospitalization as well as 180 days post discharge.
A total of 250 subjects will be enrolled into this study. Two operations (n=125) will be compared with ≥3 operations (n=125) during the hospitalization. We will compare the following factors between the two treatment groups: length of hospital stay; readmission post-discharge; quality of life; proportion of wounds closed or covered with a graft; culture results; host factors; environmental factors post-hospital discharge; and, financial charges related to admission and readmission. We expect full enrollment to take 3 years in duration.
Debridement of the wound will be performed in the customary manner per SOC in the operating room. Prior to the start of the study, the surgeons performing the operations will be required to view a video that demonstrates the standardized debridement technique that will be utilized. The following is the standardized technique depicted in the video:
All wound surfaces will be painted with dye prior to debridement. Debridement involves the use of a scalpel, scissors, curette, rongeur, or hydro-surgery. A 2-3 millimeter skin edge around the perimeter of the wound will also be resected. All infected/nonviable tissue will be removed and all tissues with dye will be surgically removed. This includes decompression of any purulent material and excision of any indurated tissue (until tissue pliability is established). Nonviable tissue includes necrotic and fibrous tissue. Debridement will be performed until the there is bleeding on the wound base and perimeter.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Infection
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
250 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
2 operations
Arm Type
Active Comparator
Arm Description
Subjects in this arm will receive a maximum of two surgical debridements of their wound.
Arm Title
3 or more operations
Arm Type
Active Comparator
Arm Description
Subjects in this arm will receive three or more surgical debridements of their wound.
Intervention Type
Procedure
Intervention Name(s)
Debridement
Intervention Description
Removing dead tissue from infected wounds.
Primary Outcome Measure Information:
Title
Number of post-hospital discharge complications between subjects who received 2 versus 3 or more debridement operations prior to closure.
Time Frame
180 Days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Infected wound requiring hospital admission
Infected wound requiring an operative intervention
Wound can be located anywhere on the body
Patient able and willing to comply with all study requirements
Exclusion Criteria:
Planned free tissue flap for soft tissue reconstruction
Wound located over exposed joint implant
Wound located over exposed hardware
Disease or treatment causing substantial immunosuppression
History of collagen vascular disease
Transplant recipient
Venous stasis ulcer
Radiation-induced ulcer
Contraindication for use of negative pressure wound therapy with instillation of normal saline
Unable or unwilling to comply with study requirements
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christopher Attinger, MD
Organizational Affiliation
MedStar Georgetown University Hospital
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Data was not collected for use in future research and will not be shared.
Learn more about this trial
Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds
We'll reach out to this number within 24 hrs